BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for the development of next-generation devices aimed at recording and modulating the human central nervous system (CNS). This initiative encourages interdisciplinary collaborations and focuses on significant risk clinical studies that require Investigational Device Exemptions (IDE) from the FDA, emphasizing real-time data synchronization and participant safety. The funding, anticipated to be around $10 million per year, will support approximately 5 to 7 awards, with a project plan that includes a Needs Assessment, an Intellectual Property Strategy, and a Long-term Care Plan for Patients. Interested applicants must submit their proposals by January 28, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.